Cargando…

Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression

Pyruvate kinase type M2, which is expressed in multiple tumor cell types and plays a key role in aerobic glycolysis, also has nonglycolytic functions and can regulate transcription and cell proliferation. The results of this study show that epidermal growth factor receptor activation induces pyruvat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Mingxiu, Tong, Yingna, Guan, Minghua, Liu, Xiaobin, Wang, Meng, Niu, Ruifang, Zhang, Fei, Dong, Dong, Shao, Jie, Zhou, Yunli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784572/ https://www.ncbi.nlm.nih.gov/pubmed/29343208 http://dx.doi.org/10.1177/1533034617749418

Ejemplares similares

Evaluation of Serological Indicators and Glomerular Filtration Rate Equations in Chinese Cancer Patients
por: Tong, Yingna, et al.
Publicado: (2017)

miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer
por: Zhou, Yu, et al.
Publicado: (2019)

PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016)

MiR‐34b/c‐5p and the neurokinin‐1 receptor regulate breast cancer cell proliferation and apoptosis
por: Zhang, Lufang, et al.
Publicado: (2018)

MKRN2 inhibits the proliferation of gastric cancer by downregulating PKM2
por: Liu, Zheng, et al.
Publicado: (2022)

Effects of lapatinib on cell proliferation and apoptosis in NB4 cells
por: Liu, Lu, et al.
Publicado: (2018)

Atg7 inhibits Warburg effect by suppressing PKM2 phosphorylation resulting reduced epithelial-mesenchymal transition
por: Feng, Yanling, et al.
Publicado: (2018)

miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2
por: Chen, Ting, et al.
Publicado: (2018)

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
por: Cristofanilli, Massimo, et al.
Publicado: (2012)

Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis
por: Gao, Peng, et al.
Publicado: (2020)

PKM2 in carcinogenesis and oncotherapy
por: He, Xia, et al.
Publicado: (2017)

Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites
por: de Sousa, Ana Carolina C., et al.
Publicado: (2020)

PolG Inhibits Gastric Cancer Glycolysis and Viability by Suppressing PKM2 Phosphorylation
por: Lv, Mengzhu, et al.
Publicado: (2021)

Erasing Sensorimotor Memories via PKMζ Inhibition
por: von Kraus, Lee Michael, et al.
Publicado: (2010)

Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells
por: Li, Luchun, et al.
Publicado: (2017)

Response of human epidermal growth factor receptor 2-positive colorectal cancer to lapatinib monotherapy: A case report
por: Guan, Ji-Lin, et al.
Publicado: (2020)

Efficacy and Tolerability of Lapatinib in the Management of Breast Cancer
por: Rana, Punam, et al.
Publicado: (2012)

Pan-Cancer Analysis of the Oncogenic and Prognostic Role of PKM2: A Potential Target for Survival and Immunotherapy
por: Liang, Nan, et al.
Publicado: (2023)

PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
por: Feng, Jiao, et al.
Publicado: (2019)

PKM and the maintenance of memory
por: Glanzman, David L.
Publicado: (2013)

Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells
por: Miao, Yi, et al.
Publicado: (2016)

Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer
por: Leung, Wing-yin, et al.
Publicado: (2015)

Lapatinib for the treatment of breast cancer in the People’s Republic of China
por: Wang, Hongjiang
Publicado: (2014)

Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect
por: Luo, Piao, et al.
Publicado: (2022)

Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma
por: Chen, Yu-Jen, et al.
Publicado: (2014)

EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts
por: YALÇIN KEHRİBAR, Demet, et al.
Publicado: (2022)

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
por: Ye, Min, et al.
Publicado: (2021)

Liposomal Lapatinib in Combination with Low-Dose Photodynamic Therapy for the Treatment of Glioma
por: Fisher, Carl, et al.
Publicado: (2019)

MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer
por: Tang, Ran, et al.
Publicado: (2016)

MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer
por: Guo, Man, et al.
Publicado: (2017)

The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2
por: Xiao, Min, et al.
Publicado: (2020)

Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients
por: Xu, Bing-He, et al.
Publicado: (2011)

No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
por: Bluemlein, Katharina, et al.
Publicado: (2011)

Platelet-rich plasma improves chronic inflammatory pain by inhibiting PKM2-mediated aerobic glycolysis in astrocytes
por: Wei, Xiang, et al.
Publicado: (2020)

PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis
por: Yang, Liangchun, et al.
Publicado: (2014)

A feedback loop between NONHSAT024276 and PTBP1 inhibits tumor progression and glycolysis in HCC by increasing the PKM1/PKM2 ratio
por: Li, Yuwei, et al.
Publicado: (2022)

Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals
por: Wang, Jun, et al.
Publicado: (2020)

Epigenetic modification of PKMζ rescues aging-related cognitive impairment
por: Chen, Chen, et al.
Publicado: (2016)

HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma
por: Zhang, Ruixue, et al.
Publicado: (2020)

A natural PKM2 targeting agent as a potential drug for breast cancer treatment
por: Shang, Xin‐Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_titdft8h0ooahiod4pvmdda8lt